TFC Financial Management’s Unicycive Therapeutics UNCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.41K Hold
300
– – ﹤0.01% 619
2026
Q2
$1.41K Hold
300
– – ﹤0.01% 613
2026
Q1
$1.97K Hold
300
– – ﹤0.01% 537
2025
Q4
$1.73K Hold
300
– – ﹤0.01% 541
2025
Q3
$1.31K Buy
+300
New +$1.31K ﹤0.01% 601

Other funds holding UNCY

TFC Financial Management's UNCY Position: Q3 2026 in Review

TFC Financial Management held its Unicycive Therapeutics (UNCY) position steady in Q3 2026 at 300 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #619.

TFC Financial Management first reported a position in UNCY in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.97K in Q1 2026. 95 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.

  • TFC Financial Management held 300 shares of Unicycive Therapeutics worth $1.41K as of Q3 2026.
  • TFC Financial Management left its Unicycive Therapeutics share count unchanged in Q3 2026.
  • Unicycive Therapeutics made up ﹤0.01% of TFC Financial Management's portfolio in Q3 2026, its #619 holding.
  • TFC Financial Management first reported a position in Unicycive Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • TFC Financial Management's Unicycive Therapeutics position peaked at $1.97K in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.

Based on TFC Financial Management's 13F filing for Q3 2026, filed 26 Oct 2026.